Pharma Marketing Network

SEPTEMBER 19, 2023

Predictive analytics is a powerful tool used across industries to analyze data and make predictions about future trends. In the pharmaceutical industry, predictive analytics is increasingly being used to help companies better understand their customers and make more informed decisions about their product development and marketing strategies.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

ALiEM - Pharm Pearls

JUNE 5, 2023

There are several forms of anthrax, however cutaneous is the most common (95% of cases) and the least complicated to treat [2]. 3, 4] Naturally occurring cases develop after spores of B. anthracis are introduced subcutaneously, often secondary to contact with infected animals or animal products. World J Clin Cases.

Vaccines 256

Vaccines 256

European Pharmaceutical Review

MARCH 1, 2024

million investment is set to support the development of innovative solutions to drive advancements in sustainable biomanufacturing in the UK. The UK Research and Innovation ( UKRI ) is backing 21 cross-sector collaborations designed to generate innovation, commercialisation and growth in this area.

Packaging 74

Packaging Pharmaceutical Manufacturing 74

Big Molecule Watch

MAY 15, 2024

The FDA subsequently, in March 2024 , approved Sandoz’s denosumab biosimilars, WYOST (denosumab-bbdz) and JUBBONTI (denosumab-bbdz), as interchangeable with Amgen’s XGEVA and PROLIA products. Stay tuned to Big Molecule Watch for further developments and check out the BPCIA Litigations Tracker for updates on additional BPCIA cases.

Biosimilars 57

Biosimilars 57

European Pharmaceutical Review

DECEMBER 14, 2023

But over time, trends in what evidence is most available and therefore most used, change. Over the past few years, we have researched the types of evidence used in regulatory decisions for drug product withdrawals due to safety concerns in Europe. Meta-analyses contributed least frequently (31.4

Medical Records 112

Medical Records Vaccines Hospitals Drug Development 112

RX Note

APRIL 5, 2024

Introduction A stretch mark (stria) is a type of scar that develops when our skin stretches or shrinks quickly. Causes If you develop stretch marks, you are most likely to do so during these times. They naturally fade and usually become less conspicuous over time, so in many cases, treatment may not be necessary.

Mayo Clinic 52

Mayo Clinic 52

Pharma and Life Sciences Blog

FEBRUARY 9, 2024

To take advantage of the increased interest in hydrogen, oil and gas leaders have to develop new distribution strategies. In this paper — The Rise of the Hydrogen Economy: An Opportunity for Oil & Gas Companies — GEP experts share their strategies for more widespread use of this fuel.

52

52

Pharmaceutical Technology

JUNE 19, 2023

Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. Laurus Labs will be responsible for launching these products in India and emerging markets.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

MARCH 8, 2024

Researchers have described the impact of data integrity, GAMP 5 and quality by design (QbD) principles on pharmaceutical quality assurance (QA) , highlighting the importance of data integrity through various case studies. Data integrity guarantees the reliability of data collected throughout various stages of drug development.”

Drug Development 82

Drug Development 82

Express Pharma

AUGUST 8, 2023

The Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals announced a new funding agreement to advance the development of their self-amplifying mRNA (saRNA) platform to develop vaccine candidates against unknown pathogenic threats, also referred to as Disease X. CEPI will provide up to $3.6

Vaccines 94

Vaccines Immunity Immunization 94

FDA Law Blog: Biosimilars

MARCH 3, 2024

To state the inverse, the Act does not apply in cases where federal contractors do not use “biotechnology equipment or services” acquired from a “biotechnology company of concern” to perform the services under the contract—as each term is defined in the Act. HPM will continue to monitor developments related to the Act.

Packaging 102

Packaging 102

PharmaState Academy

FEBRUARY 19, 2024

CASE STUDY Implementing a Communication Protocol for Multinational Product Launch Table of Contents Case Study AlphaPharma, a leading multinational pharmaceutical company, is on the brink of launching a groundbreaking new medication called “NeuroPlus,” designed to treat a rare neurological disorder that affects.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

PharmaState Academy

FEBRUARY 19, 2024

CASE STUDY Implementing a Communication Protocol for Multinational Product Launch Table of Contents Case Study ABCgenix Pharma, a leading multinational pharmaceutical company, is on the brink of launching a groundbreaking new medication called “XYzyme,” designed to treat a rare neurological disorder that affects.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

PharmaState Academy

MARCH 1, 2024

CASE STUDY Navigating Objections and Cultivating Pharmacy Partnerships A Strategic Approach for Pharma Companies Table of Contents Case Study Scenario: You’re leading a dynamic sales team at XYZ Pharma, a renowned player in the pharmaceutical industry renowned for its innovative medications targeting chronic conditions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Diabetes 52

PharmaState Academy

MARCH 1, 2024

CASE STUDY Navigating Objections and Cultivating Pharmacy Partnerships A Strategic Approach for Pharma Companies Table of Contents Case Study Scenario: You’re leading a dynamic sales team at XYZ Pharma, a renowned player in the pharmaceutical industry renowned for its innovative medications targeting chronic conditions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Diabetes 52

pharmaphorum

OCTOBER 25, 2022

Healthware, as the key R&D partner, has been supporting Orion Corporation to design and develop a novel treatment, a Digital Therapeutics software solution “ Rohkea ” to treat Chronic Pain ( DTxP ) using Virtual Reality ( VR ). The attendance is free but requires registration here.

91

91

European Pharmaceutical Review

JULY 1, 2022

A recent paper outlines a process that can be used to select and document worst-case sampling locations to validate cleaning processes. This was the primary information supporting the identification of worst-case sampling locations for cleaning validation. Selection of sampling methods, eg, swab or rinse sampling.

Documentation 100

Documentation Pharmaceutical Manufacturing 100

ID Stewardship

APRIL 14, 2024

PharmD, BCPS, BCIDP, AAHIV-M Disclaimer : This text and table is intended for use as a study tool to assist people learning pharmacotherapy of recurrent Clostridioides difficile infections (rCDI). Most cases of C. Source : CDC.gov Consequences of Antibiotic Use Antibiotic use, which can include treatment of C.

Hospitals 129

Hospitals Communication 129

Big Molecule Watch

MAY 1, 2023

On April 25, 2023, Bristol-Myers Squibb (“BMS”) filed a complaint in the District of Delaware against AstraZeneca related to AstraZeneca’s anti-PD-L1 antibody product, IMFINZI (durvalumab), alleging willful infringement of U.S. This is the second case that BMS has filed against AstraZeneca alleging infringement of the ‘899 patent.

62

62

FDA Law Blog: Biosimilars

MARCH 5, 2024

Gaulkin & Riëtte van Laack — As readers of this blog know, there is a lot of contention about the naming of alternative protein products (APPs), including both plant-based and cell-cultured alternatives for (traditional) animal products. We’ve previously blogged about this ongoing battle here , here , here , and here.

Labelling 59

Labelling 59

PharmaState Academy

FEBRUARY 29, 2024

CASE STUDY Seizing Opportunities Launching a Revolutionary Pharmaceutical Product Across Diverse Tier 2 Cities Table of Contents Case Study Introduction: Introduction to the case study focusing on launching a new pharmaceutical product in multiple Tier 2 cities in India.

Health and Personal Care Stores 52

Health and Personal Care Stores Hospitals Communication Customer Service 52

European Pharmaceutical Review

JANUARY 9, 2024

Considering the transformative power of data, by drawing on an abundance of information and making best use of emerging technologies, we see the potential for reshaping decision-making. Another challenge is regulatory compliance, where AI systems must meet stringent requirements for validation of the data used and quality assurance.

Pharmaceutical Manufacturing 122

Pharmaceutical Manufacturing Drug Development 122

Pharmaceutical Technology

MAY 25, 2023

ElevateBio has raised $401m in a Series D financing round for advancing its technology platforms to expedite the design, production and development of cell and gene therapies. ElevateBio intends to use the funds to advance its genetic medicine current good manufacturing practice (cGMP) and process development business, BaseCamp.

97

97

pharmaphorum

NOVEMBER 25, 2022

There are clearly challenges to developing a drug targeting a rare disease, due to the small and often undiagnosed populations, and these challenges are also present when developing an accurate forecast of their market potential. Case study: severe asthma. Case study: CAR-T treatment. Data and market insights.

Immunity 121

Immunity Immunization Hospitals 121

Pharmaceutical Technology

MARCH 29, 2023

Regeneron Pharmaceuticals has collaborated with Sonoma Biotherapeutics to discover, develop and commercialise new regulatory T cell (Treg) therapies for autoimmune diseases. The two companies will together research and develop T cell therapies for Crohn’s disease and ulcerative colitis, as well as two other undisclosed indications.

98

98

European Pharmaceutical Review

NOVEMBER 11, 2022

Developments need to be made to enable lower dosages and toxicity, limit adverse effects and find better treatment efficacy of ocular drugs, it stated. Development of suitable analytical procedures to help detect and quantify the degradation of products is a key objective, according to the authors. analogues to treat glaucoma.

Dosage 89

Dosage 89

Big Molecule Watch

MAY 10, 2023

This is Amgen’s first BPCIA case filed with respect to a denosumab biosimilar. Amgen seeks a declaratory judgement of infringement of twenty-one patents that, according to Amgen, “cover denosumab (the active ingredient in Prolia and XGEVA) and methods of manufacturing denosumab and denosumab products.”

Biosimilars 70

Biosimilars 70

Pharmaceutical Technology

MAY 19, 2023

Myeloid Therapeutics has raised $73m to support the continued clinical development of its lead cell therapy programme, MT-101, in Phase I/II trials for T cell lymphoma. The financing will help to fast-track the development of other in vivo programming candidates into clinical trials.

Labelling 98

Labelling 98

PharmaState Academy

MARCH 1, 2024

CASE STUDY Mastering Detailing Sessions with Doctors Securing Prescriptions through Effective Presentations Table of Contents Case Study Scenario: Imagine you’re leading a team of pharmaceutical sales representatives at XYZ Pharma, a leading player in the industry. Option 01 Ignoring the doctor's objections.

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JULY 4, 2023

As drug development professionals know, global health crises like the COVID-19 pandemic provide the public with valuable insights into how clinical research and regulatory processes work. What are Antibody Drug Conjugates and Multispecific Antibody Therapeutics?

Drug Development 80

Drug Development Communication Dosage Chemotherapy 80

European Pharmaceutical Review

JANUARY 23, 2023

There are major concerns about microbial contamination in cannabis, US Food and Drug Administration (FDA) researchers observed in a study. Multiple cases have been reported of infections associated with cannabis use caused by fungi and bacteria in immunocompromised individuals using inhaled cannabis material.

Compounding 114

Compounding 114

European Pharmaceutical Review

JANUARY 29, 2024

During 2023, there were five revisions to the European Medicines Agency ’s (EMA’s) Questions and Answers (Q&As) for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products. These changes are summarised in Table 1.

Drug Development 96

Drug Development Vaccines Compounding 96

European Pharmaceutical Review

JANUARY 12, 2024

Using an investment of €120 million, Boehringer Ingelheim is set to expand and upgrade its production site in Koropi, Greece. The expansion will boost exports of medicines from Greece to the US market. In 2020, the company announced multi-year investments to expand the site and its production capacity. “We

Diabetes 94

Diabetes Pharmaceutical Companies Pharmaceutical Companies 94

European Pharmaceutical Review

JANUARY 4, 2024

As a system that uses various technologies , such as data analytics and artificial intelligence (AI), to transfer data between each other autonomously in an industrial setting, IIoT “enables wide-scope data collection and utilisation, and reduces errors, increases efficiency, and provides an improved understanding of the process in return”.

94

94

Quality Matters

DECEMBER 8, 2023

In some cases, the analytical methods used to quantitate NDSRIs may not be sufficiently sensitive to quantify the impurities at limits defined as acceptable for CPCA categories 1 through 3. Product recalls are also a real risk. Product recalls are also a real risk. Technical limitations also exist.

94

94

pharmaphorum

JUNE 10, 2022

A device means a product that’s used in the diagnosis of disease and intended to affect the structure and function of the body of humans,” Faget said. In the case of a combination product, like a respiratory drug prescribed alongside a smart inhaler, the drug and the device both have to go through their respective processes.

Documentation 133

Documentation 133

PharmaState Academy

MARCH 4, 2024

By examining multiple cases, we aim to identify common challenges, successful strategies, and key learnings in managing travel schedules for optimal coverage, offering valuable insights for sales professionals seeking to improve their time management skills. Let us gain more insights into the case study!

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52